Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term opioid administration in oncologic chronic pain
2008-002273-12Phase 4Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- May 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morphine, oxycodone, fentanyl, buprenorphine and hydromorphone in cancer pain and chronic pain (5 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Pain reduction on VAS. Started May 2008; status: terminated.
02
Drugs
morphineoxycodonefentanylbuprenorphinehydromorphone
03
Conditions
cancer painchronic pain
Beyond the preview
Go deeper on 2008-002273-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002273-12.